Despite pockets of mid-market uncertainty, ServiceNow (NYSE:NOW) continues to generate consistent enterprise deals, which ...

Tesla (NASDAQ:TSLA) is about to unveil its Q1 delivery figures, and expectations are so low that even its most rabid fans are ...

Stifel analysts, led by Stephen Gengaro, lowered their short-term expectations for EV maker Tesla (TSLA) due to the negative ...

BOSTON & MONTREAL, April 01, 2025--enGene Holdings Inc. (Nasdaq: ENGN or "enGene" or the "Company"), a clinical-stage, ...

The subsidies currently underpinning many of the UK's renewable energy projects are due to expire in the next decade, leaving ...

RH (NYSE:RH – Get Free Report) had its target price cut by equities research analysts at Stifel Nicolaus from $500.00 to $450 ...

Learn more about whether Stifel Financial Corp. or Victory Capital Holdings, Inc. is a better investment based on AAII's A+ ...

Citing headwinds from the “anti Elon Musk crowd” and declining favorability among Tesla's (NASDAQ:TSLA) target demographic, ...

Tesla (NASDAQ:TSLA – Get Free Report) had its target price cut by analysts at Stifel Nicolaus from $474.00 to $455.00 in a ...

Learn more about whether Hamilton Lane Incorporated or Stifel Financial Corp. is a better investment based on AAII's A+ ...

It was a historically difficult quarter for the EV maker, with tariffs and growing protests over Elon Musk's work with DOGE ...

Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA ...